OncLive: Dr. Mesa on the efficacy of fedratinib in patients with myelofibrosis and low platelet counts

Ruben A. Mesa, MD, director, The Mays Cancer Center, the newly named center of UT Health San Antonio MD Anderson Cancer Center, discusses the efficacy of fedratinib in patients with myelofibrosis who have low platelet counts.

Read the full story at OncLive



Share This Article!